Pharmacological effects of HMG CoA reductase inhibitors other than lipoprotein modulation.
about
Administration of simvastatin after kainic acid-induced status epilepticus restrains chronic temporal lobe epilepsy.Cerivastatin-induced rhabdomyolysis: 11 case reports.Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductaseLong-term benefits after treatment of traumatic brain injury with simvastatin in rats.The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study.The effect of HMG-CoA reductase inhibitors on chronic allograft rejection.
P2860
Pharmacological effects of HMG CoA reductase inhibitors other than lipoprotein modulation.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pharmacological effects of HMG ...... r than lipoprotein modulation.
@ast
Pharmacological effects of HMG ...... r than lipoprotein modulation.
@en
Pharmacological effects of HMG ...... r than lipoprotein modulation.
@nl
type
label
Pharmacological effects of HMG ...... r than lipoprotein modulation.
@ast
Pharmacological effects of HMG ...... r than lipoprotein modulation.
@en
Pharmacological effects of HMG ...... r than lipoprotein modulation.
@nl
prefLabel
Pharmacological effects of HMG ...... r than lipoprotein modulation.
@ast
Pharmacological effects of HMG ...... r than lipoprotein modulation.
@en
Pharmacological effects of HMG ...... r than lipoprotein modulation.
@nl
P2860
P1476
Pharmacological effects of HMG ...... r than lipoprotein modulation.
@en
P2093
P2860
P304
P356
10.1177/00912709922007642
P577
1999-02-01T00:00:00Z